Cyclophosphamide induction dose and outcomes in ANCA-associated vasculitis with renal involvement: A comparative cohort study

Treatment of ANCA-associated vasculitis (AAV) improved over the last decades but disease-unspecific agents such as cyclophosphamide are still associated with serious adverse events, including high rates of infectious complications and malignancy with increased mortality. In this comparative cohort s...

Descripción completa

Detalles Bibliográficos
Autores principales: Speer, Claudius, Altenmüller-Walther, Christine, Splitthoff, Jan, Nusshag, Christian, Kälble, Florian, Reichel, Paula, Morath, Christian, Zeier, Martin, Bergner, Raoul, Schaier, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294897/
https://www.ncbi.nlm.nih.gov/pubmed/34398050
http://dx.doi.org/10.1097/MD.0000000000026733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294897/
https://www.ncbi.nlm.nih.gov/pubmed/34398050
http://dx.doi.org/10.1097/MD.0000000000026733

Ejemplares similares